High plasma levels of soluble endothelial protein C receptor are associated with increased mortality among children with cerebral malaria in benin

Journal of Infectious Diseases

Volumn 211, Issue 9, 2015, Pages 1484-1488

  Moussiliou, Azizath ^a,b,c   Alao, Maroufou J ^d   Denoeud Ndam, Lise ^a,b   Tahar, Rachida ^a,b   Ezimegnon, Sem ^e   Sagbo, Gratien ^f   Amoussou, Annick ^g   Luty, Adrian J F ^a,b   Deloron, Philippe ^a,b   Tuikue Ndam, Nicaise ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Hôpital Mère enfant de la Lagune   (Germany)

^e UNIVERSITY OF ABOMEY CALAVI   (Benin)

^f Centre National Hospitalo universitaire   (Benin)

^g Hôpital de Zone de Suru Léré   (Benin)

Author keywords

Cerebral malaria; EPCR; Plasmodium; Protein C; sEPCR

Indexed keywords

ARTEMISIN; ENDOTHELIAL PROTEIN C RECEPTOR; QUININE; ANTIMALARIAL AGENT; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; PROCR PROTEIN, HUMAN;

ARTICLE; BENIN; BRAIN MALARIA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL PROTEIN C RECEPTOR GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; BLOOD; MALARIA, CEREBRAL; METABOLISM;

ANTIGENS, CD; ANTIMALARIALS; BENIN; CHILD, PRESCHOOL; GENOTYPE; HUMANS; MALARIA, CEREBRAL; QUININE; RECEPTORS, CELL SURFACE;

EID: 84928911761     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu661     Document Type: Article

References (14)

1. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001; 64:57-67.
2. Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pe-diatr Res 2010; 68:267-74.
3. Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 2013; 498:502-5.
4. Hayashi T, Nakamura H, Okada A, et al. Organization and chromosomal localization of the human endothelial protein C receptor. Gene 1999; 238:367-73.
5. Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, Esmon CT. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 1996; 271:17491-8.
6. Regan LM, Stearns-Kurosawa DJ, Kurosawa S, Mollica J, Fukudome K, Esmon CT. The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem 1996; 271: 17499-503.
7. Xu J, Qu D, Esmon NL, Esmon CT. Metalloproteolytic release of endo-thelial cell protein C receptor. J Biol Chem 2000; 275:6038-44.
8. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2004; 2: 1305-10.
9. Patarapotikul J, Hananantachai H, Imai H, Ohashi J. Association of the endothelial protein C receptor (PROCR) rs867186-G allele with protection from severe malaria. Malar J 2014; 13:105.
10. Moxon CA, Wassmer SC, Milner DA Jr, et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 2013; 122:842-51.
11. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94:S1-90.
12. Wooden J, Kyes S, Sibley CH. PCR and strain identification in Plasmo-dium falciparum. Parasitol Today 1993; 9:303-5.
13. Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 2004; 103:1311-8.
14. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376: 1647-57.